Trade

with

Retrophin Inc
(NASDAQ: RTRX)
AdChoices
9.41
-0.14
-1.47%
After Hours :
9.41
+0.00
+0.01%

Open

9.67

Previous Close

9.55

Volume (Avg)

302.79k (338.16k)

Day's Range

9.33-9.69

52Wk Range

7.85-24.25

Market Cap.

251.07M

Dividend Rate ( Yield )

-

Beta

0.19

Shares Outstanding

26.68M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • -9.78M

    • Net Income

    • -33.82M

    • Market Cap.

    • 251.07M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.19

    • Forward P/E

    • -

    • Price/Sales

    • -6.78

    • Price/Book Value

    • 238.10

    • Price/Cash flow

    • -6.45

      • EBITDA

      • -33.53M

      • Return on Capital %

      • -108.94

      • Return on Equity %

      • -

      • Return on Assets %

      • -108.94

      • Book Value/Share

      • 0.04

      • Shares Outstanding

      • 26.68M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 39.00

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -1.03

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -

          • 7.80

          • Net Income

            Q/Q (last year)

          • -

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 6.10

          • Net Income

            5-Year Annual Average

          • -

          • 3.73

          • Dividends

            5-Year Annual Average

          • -

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -

            • 69.92

            • Pre-Tax Margin

            • -

            • 21.84

            • Net Profit Margin

            • -

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 77.63

              • 0.32

              • Current Ratio

              • -

              • 1.92

              • Quick Ratio

              • -

              • 1.31

              • Interest Coverage

              • -

              • 17.64

              • Leverage Ratio

              • 145.79

              • 2.03

              • Book Value/Share

              • 0.04

              • 14.62

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -2.40

                • 22.62

                • P/E Ratio 5-Year High

                • -5.83

                • 193.96

                • P/E Ratio 5-Year Low

                • -0.22

                • 87.26

                • Price/Sales Ratio

                • -7.20

                • 3.79

                • Price/Book Value

                • 250.00

                • 3.78

                • Price/Cash Flow Ratio

                • -6.45

                • 14.31

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -

                        (-)

                      • 17.42

                        (18.66)

                      • Return on Assets %

                        (5-Year Average)

                      • -108.94

                        (-)

                      • 8.45

                        (8.77)

                      • Return on Capital %

                        (5-Year Average)

                      • -

                        (-)

                      • 12.41

                        (13.18)

                      • Income/Employee

                      • -

                      • 90.07k

                      • Inventory Turnover

                      • -

                      • 2.46

                      • Asset Turnover

                      • -

                      • 0.46

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -33.75M
                      Operating Margin
                      345.22
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -6.45
                      Ownership

                      Institutional Ownership

                      72.95%

                      Top 10 Institutions

                      60.03%

                      Mutual Fund Ownership

                      15.01%

                      Float

                      84.89%

                      5% / Insider Ownership

                      14.86%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Putnam Global Health Care Fund

                      •  

                        672,000

                      • 0.00

                      • 2.55

                      • iShares Russell 2000 (AU)

                      •  

                        326,268

                      • -1.80

                      • 1.29

                      • Prudential Jennison Health Sciences

                      •  

                        317,938

                      • 0.00

                      • 1.19

                      • Vanguard Total Stock Mkt Idx

                      •  

                        275,067

                      • 0.00

                      • 1.03

                      • Deutsche Global Small Cap Fund

                      •  

                        223,500

                      • 0.00

                      • 0.84

                      • Deutsche Global Growth Fund

                      •  

                        186,709

                      • 0.00

                      • 0.70

                      • Turner Medical Sciences Long/Short

                      •  

                        165,530

                      • 60.97

                      • 0.62

                      • FCP OP MEDICAL BioHealthTrends

                      •  

                        157,498

                      • -26.23

                      • 0.59

                      • iShares Russell 2000 Growth

                      •  

                        151,190

                      • -1.58

                      • 0.60

                      • CREF Stock

                      •  

                        143,759

                      • 0.00

                      • 0.54

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Jennison Associates LLC

                      •  

                        3,201,470

                      • +62.53%

                      • 12.17

                      • Qvt Financial LP

                      •  

                        2,287,583

                      • 0.00%

                      • 8.59

                      • RRC Management LLC

                      •  

                        1,889,824

                      • +372.46%

                      • 10.26

                      • Broadfin Capital, LLC

                      •  

                        1,675,251

                      • +4.07%

                      • 6.37

                      • Perceptive Advisors LLC

                      •  

                        1,274,292

                      • +22.02%

                      • 4.84

                      • Opaleye Management Inc

                      •  

                        1,216,400

                      • +5.48%

                      • 4.62

                      • Putnam Investment Management,LLC

                      •  

                        940,936

                      • -33.44%

                      • 3.58

                      • Lombard Odier Asset Management USA Corp

                      •  

                        600,000

                      • +33.33%

                      • 2.28

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Major

                      Type

                      Distressed

                      Style

                      -

                      Retrophin, Inc., was incorporated as Desert Gateway, Inc. as an Oklahoma corporation on February 8, 2008. On February 14, 2013, the Company changed its name to Retrophin, Inc. The Company is a fully integrated biopharmaceutical compa...moreny focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic or rare diseases. It is developing Syntocinon Nasal Spray in the U.S. to assist initial postpartum milk ejection, which it refers to as aiding milk let-down, and for the treatment of Schizophrenia and Autism. It is also developing RE-034, a synthetic hormone analogue that is composed of the first 24 amino acids of the 39 amino acids contained in the naturally occurring adrenocorticotrophic hormone, or ACTH, for the treatment of Infantile Spasms, or IS,...more and Nephrotic Syndrome, or NS. It is developing sparsentan, formerly known as RE-021, a dual acting receptor antagonist of angiotensin and endothelin receptors, for the treatment of focal segmental glomerulosclerosis, or FSGS. The Company competes with Genentech, GlaxoSmithKline, Roche, Novartis, Pfizer, Boehringer Ingelheim, Sanofi, BioMarin, Sarepta, Vertex, and Jazz Pharmaceuticals. The Company is subject to federal, state and local laws governing the use, handling and disposal of these materials.lessless

                      Key People

                      Steve Aselage

                      COO/Director/President/CEO

                      Marc L. Panoff

                      CFO/Chief Accounting Officer

                      Dr. Alvin Shih, M.D.

                      Executive VP, Divisional/Chief Medical Officer

                      Cornelius E. (Neal) Golding

                      Director

                      Mr. Gary A. Lyons

                      Director

                      • Retrophin Inc

                      • 777 Third Avenue

                      • New York, NY 10017

                      • USA.Map

                      • Phone: +1 646 837-5863

                      • Fax: -

                      • retrophin.com

                      Incorporated

                      2008

                      Employees

                      26

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: